Welcome Cure raises Half a million $ in Pre-series A Round led by Inflection Point Ventures in its on-going Funding Round

0
134
Welcome Cure raises Half a million $ in Pre-series A Round led by Inflection Point Ventures in its on-going Funding Round
Welcome Cure raises Half a million $ in Pre-series A Round led by Inflection Point Ventures in its on-going Funding Round
  • Welcome Cure is a fully integrated homoeopathy technology company that offers Assisted intelligence (AI)-powered solutions for doctors and patients, ensuring both effective prescriptions and convenient access to healthcare regardless of location

  • The funds will be utilised for growth, including talent acquisition, technology enhancement, and marketing initiatives.

  • Inflection Point Ventures (IPV) has so far invested over INR 600 crore across 190+ deals.

Mumbai,October 19, 2023: Welcome Cure has raised over 4 crore in the pre-series A round led by Inflection Point Ventures (IPV). The funds will be utilised for growth, including talent acquisition, technology enhancement, and marketing initiatives. IPV has led the round, and Welcome Cure is looking at raising over Rs 16 crore in this ongoing funding round.

Welcome Cure addresses the growing demand for sustainable and holistic healthcare by providing a comprehensive one-stop solution in the fragmented homoeopathy market, offering convenient online and offline services for diagnosis, treatment, and monitoring, with a focus on prevention and overall well-being.

Welcome Cure is led by a team of experienced and accomplished individuals. Dr. Jawahar Shah, the founder, brings 45 years of clinical practice as an MD in homoeopathy and holds a post-graduate degree from London. Punit Desai, the co-founder and CEO, contributes his expertise with an MBA and over 10 years of entrepreneurship experience. Nidhi Desai, the co-founder and COO, also brings an MBA and over 10 years of entrepreneurship experience to the team. Together, they form a strong leadership team that drives Welcome Cure’s mission to provide holistic healthcare solutions through their innovative platform.

Vikram Ramasubramanian, Partner, Inflection Point Ventures, says, “While homoeopathy treatment is well recognised across the globe, the number of people opting for such treatment is also growing exponentially. The main reason for such acceptance is the ability to provide treatment for the root cause, especially chronic disease, which is recurring and needs utmost attention. Welcomecure, with its unique healthcare solution, has been able to offer its patients much-needed treatment regardless of location. The brand itself has grown multifold with its ability to offer seamless interaction between its patients and doctors, onboard the best carers and experts in homoeopathic medicine, and provide a holistic solution all under one roof. We at IPV look forward to scaling their new-age business with strategic guidance and enabling the brand to benefit more and more individuals”.

Welcome Cure operates at an impressive scale, with 2.5 million platform users and 1.5 million+ registered patients in 36+ countries. Their software business serves over 1 lakh doctors in 140+ countries.

Welcome Cure stands out in the healthcare industry with its modernised homoeopathy and holistic care solutions, catering to patients’ needs in a comprehensive manner. Their unique proposition lies in the integration of proprietary Assisted Intelligence (AI) solutions, which serve as a valuable decision support system for physicians. This AI-powered technology enhances diagnostic accuracy, treatment selection, and monitoring, ensuring optimal patient care. Welcome Cure’s commitment to an integrated and 360-degree technology-powered solution further solidifies their position as leaders in the homoeopathy domain.

Dr. Jawahar Shah, Founder, Welcome Cure, says, “Homoeopathy has been around for more than 200 years, grown consistently, and served humanity. It enjoys acceptance from all socio-economic classes and has a wide presence across the world. As per the WHO, it is the second-largest system of medicine and is used in over 100 countries. In a $9 billion+ market, there is immense potential as it’s growing at over 18% CAGR, and there is a missing brand, which is a name synonym for homeopathy. Welcome Cure desires to do that and be that. Emerge as the first choice when anyone thinks of homoeopathic are. With IPV’s participation in Welcome Cure as an equity and growth investor, we are poised to make this vision come to light.”

Welcome Cure has achieved remarkable organic growth since its inception, with a positive return for the past two years. Within the last couple of years alone, the company has achieved a cumulative business of over 45 crores, demonstrating its strong presence in the alternative medicine space. The startup and its founders have also received recognition and accolades from esteemed institutions and bodies, including testimonials and awards from Prime Minister Narendra Modi, the Ministry of Electronics & IT, and other prestigious organisations.

The homoeopathy industry is currently valued at over 7 billion USD and is experiencing a growth rate of 18% CAGR (compound annual growth ate). Projections indicate that the industry is expected to surpass 21 billion USD within the next 5 to 7 years, indicating significant growth potential in the near future.

Also readIT cybersecurity aims to ensure that stakeholders can access and process data when necessary, says Srikanth Subbu CISO at Tata Electronics

Do FollowCIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter 

About us:

CIO News, a proprietary of Mercadeo, produces award-winning content and resources for IT leaders across any industry through print articles and recorded video interviews on topics in the technology sector such as Digital Transformation, Artificial Intelligence (AI), Machine Learning (ML), Cloud, Robotics, Cyber-security, Data, Analytics, SOC, SASE, among other technology topics.